Publications by authors named "Montserrat Bach-Oller"
Article Synopsis
- The study compares patients with a single syncopal episode (SSE) and those with recurrent syncopal episodes (RSE) who also have complete bundle branch block (cBBB), focusing on arrhythmic risk and clinical outcomes.
- Results show that both groups have similar risks for arrhythmic syncope and similar rates of diagnostic yield from electrophysiological studies and implantable cardiac monitors.
- The findings suggest that there is no clinical reason to treat patients with SSE differently from those with RSE, as they experience comparable outcomes and risks.
Objective: To analyze if there are sex-related differences in patients with unexplained syncope and bundle branch block (BBB).
Background: Despite increasing awareness that sex is a major determinant of the incidence, etiology, and the outcomes of different arrhythmias, no studies have examined differences in presentation and outcomes between men and women with syncope and BBB.
Methods: Cohort study of consecutive patients with unexplained syncope and BBB was included from January 2010 to January 2021 with a median follow-up time of 3.
Article Synopsis
- Patients with ST-segment elevation myocardial infarction (STEMI) after transcatheter aortic valve replacement (TAVR) face higher risks compared to non-TAVR patients, particularly in terms of mortality.
- The study analyzed 118 TAVR patients with STEMI and found longer door-to-balloon times, increased procedural durations, and higher rates of PCI failure compared to a control group of non-TAVR STEMI patients.
- Key risk factors for increased mortality included reduced kidney function, higher Killip class (indicating worsening heart failure), and failure of the PCI procedure itself.
Background: Scarce data exist on coronary events following transcatheter aortic valve replacement (TAVR), and no study has determined the factors associated with poorer outcomes in this setting. This study sought to determine the clinical characteristics, outcomes, and prognostic factors of acute coronary syndrome (ACS) events following TAVR.
Methods: Multicenter cohort study including a total of 270 patients presenting an ACS after a median time of 12 (interquartile range, 5-17) months post-TAVR.